@ActRrct
AcT is a Pragmatic Phase III randomized open-label registry-based trial with blinded end-point assessment, comparing tPA with TNK in acute ischemic stroke.
@PramodBoroBTR
@HonEdFast
@m5418mrz
@0lz0O7m74JHWxth
@xmd22
@shrikes0e
@PlayfixLab
@Knockhardy
@DanielRicabal15
@sheamermaidx
@Lexikin_asmr
@AtishiAAP
@joshua1st523
@tangur
@TripleOption29
@PiramideRossa
@Raiatenta
@p1VwU3lH1qJn6xC
@F1Christoffer
@CustomlyticsDE
No tweets found